Advisory Committee on Immunization Practices (ACIP)
The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.
Select all docs (Max 200)
Narrow Results:
More
More
More
More
More
More
Publish Year
- 2022 128
- 2021 238
- 2020 129
- 2019 104
- 2018 133
- 2017 116
- 2016 98
- 2015 77
- 2014 117
- 2013 102
- 2012 110
- 2011 14
- 2010 20
- 2009 14
- 2008 14
- 2007 10
- 2006 13
- 2005 9
- 2004 8
- 2003 16
- 2002 12
- 2001 6
- 2000 13
- 1999 10
- 1998 5
- 1997 10
- 1996 11
- 1995 4
- 1994 7
- 1993 5
- 1992 5
- 1991 9
- 1990 6
- 1989 5
- 1988 4
- 1987 4
- 1986 4
- 1985 3
- 1984 4
- 1983 3
- 1982 3
- 1981 3
- 1980 2
- 1979 3
- 1978 3
- 1977 3
- 1976 7
- 1975 3
- 1974 3
- 1973 2
- 1972 3
- 1971 3
- 1970 2
- 1969 4
- 1968 3
- 1967 3
- 1966 2
- 1965 2
- 1954 1
Genre
- Abbreviations 1
- Bibliography 1
- Blogs 1
- Chronology 1
- Conference Publications 1326
- Fact Sheet 2
- Guidance 11
- Guideline 8
- Guidelines 1
- Historical Article 1
- Map 1
- Practice Guideline 74
- Review 1
- Standards 2
Document Type
- Agenda 66
- Guideline 1
- HAN Health Update 1
- Journal Article 126
- Journal Issue 100
- Minutes 193
- Newsletter 1
- Pamphlet (or booklet) 32
- Presentation 1074
- Published Erratum 1
- Report 4
- Table 1
- Webpage 3
Subject
- administration & dosage 32
- Adolescent 103
- Adult 99
- Adverse Drug Reaction Reporting Systems 29
- adverse effects 20
- Advisory Committees 61
- Aged 46
- Aged, 80 and over 12
- Age Factors 16
- Anthrax Vaccines 17
- Antiviral Agents 20
- Articles 17
- Chickenpox Vaccine 12
- Child 126
- Child, Preschool 98
- Cholera Vaccines 12
- contraindications 13
- Coronavirus Infections 16
- Coronavirus Infections/prevention &control 44
- Coronavirus Infections/prevention & control 195
- COVID-19 60
- COVID-19 Vaccines 210
- COVID-19 Vaccines/adverse effects 21
- COVID-19/prevention & control 89
- Decision Making 18
- Dengue 13
- Dengue Vaccines 18
- Diphtheria-Tetanus-acellular Pertussis Vaccines 22
- Disease Outbreaks 29
- Drug-Related Side Effects and Adverse Reactions 13
- Ebola Vaccines 17
- Female 35
- Full Report 22
- GRADE Approach 35
- Haemophilus Vaccines 12
- Health Personnel 21
- Hepatitis A Vaccines 29
- Hepatitis B 12
- Hepatitis B Vaccines 43
- Herpes Zoster Vaccine 37
- Humans 146
- Immunization 334
- Immunization, Secondary 68
- Immunization/standards 46
- Immunization Programs 307
- Immunization Schedule 177
- Immunocompromised Host 16
- Infant 93
- Infant, Newborn 29
- Influenza, Human 47
- Influenza, Human/prevention & control 15
- Influenza A virus 13
- Influenza A Virus, H1N1 Subtype 13
- Influenza B virus 19
- Influenza Vaccines 159
- Influenza Vaccines/adverse effects 12
- Influenza Vaccines 12
- Japanese Encephalitis Vaccines 32
- Licensure 12
- Male 27
- Mass Vaccination 12
- Measles-Mumps-Rubella Vaccine 29
- Meningococcal Infections 17
- Meningococcal Vaccines 86
- Middle Aged 47
- Myocarditis 13
- Pandemics 150
- Papillomavirus Vaccines 53
- Papillomavirus Vaccines 34
- Patient Safety 44
- Pertussis Vaccine 34
- Pneumococcal Infections 14
- Pneumococcal Vaccines 72
- Practice Guidelines as Topic 34
- Pregnancy 31
- prevention & control 34
- Program Evaluation 15
- Public Health Surveillance 12
- Rabies Vaccines 12
- Risk Assessment 12
- Risk Factors 16
- Safety 25
- Seasons 14
- Smallpox Vaccine 15
- standards 43
- Travel 19
- Vaccination 576
- Vaccination/adverse effects 13
- Vaccination/standards 19
- Vaccines 317
- Vaccines, Attenuated 22
- Vaccines, Combined 19
- Vaccines, Conjugate 19
- Vaccines, Inactivated 21
- Vaccines/administration & dosage 45
- Vaccines/supply & distribution 18
- Viral Hepatitis Vaccines 12
- Viral Vaccines 154
- Yellow Fever Vaccine 12
- Young Adult 28
Name as Subject
- ACIP Meeting 2021 April 23 2
- ACIP Meeting 2021 January 27 4
- ACIP meeting: 1975 Oct 2
- ACIP meeting: 2002 Feb 2
- ACIP meeting: 2002 Jun 2
- ACIP meeting: 2002 Oct 2
- ACIP meeting: 2003 Feb 2
- ACIP meeting: 2003 Jun 2
- ACIP meeting: 2003 Oct 3
- ACIP meeting: 2012 Jun 5
- ACIP meeting: 2012 Oct 37
- ACIP meeting: 2013 Feb 28
- ACIP meeting: 2013 Jun 28
- ACIP meeting: 2013 Oct 33
- ACIP meeting: 2014 Aug 4
- ACIP meeting: 2014 Feb 33
- ACIP meeting: 2014 Jun 37
- ACIP meeting: 2014 Oct 29
- ACIP meeting: 2015 Feb 13
- ACIP meeting: 2015 Jun 31
- ACIP meeting: 2015 Oct 22
- ACIP meeting: 2016 Feb 22
- ACIP meeting: 2016 Jun 35
- ACIP meeting: 2016 Oct 39
- ACIP meeting: 2017 Feb 35
- ACIP meeting: 2017 Jun 29
- ACIP meeting: 2017 Oct 50
- ACIP meeting: 2018 Feb 35
- ACIP meeting: 2018 Jun 30
- ACIP meeting: 2018 Oct 36
- ACIP meeting: 2019 Feb 38
- ACIP meeting: 2019 Jun 33
- ACIP meeting: 2019 Oct 20
- ACIP meeting: 2020 Aug 8
- ACIP meeting: 2020 Dec 01 5
- ACIP meeting: 2020 Dec 11 5
- ACIP meeting: 2020 Dec 11-12 3
- ACIP meeting: 2020 Dec 19-20 10
- ACIP meeting: 2020 Feb 26
- ACIP meeting: 2020 Jul 11
- ACIP meeting: 2020 Jun 14
- ACIP meeting: 2020 Nov 9
- ACIP meeting: 2020 Oct 13
- ACIP meeting: 2020 Sep 10
- ACIP meeting: 2021 Apr. 14 5
- ACIP meeting: 2021 Apr. 23 6
- ACIP meeting: 2021 Aug 13 6
- ACIP meeting: 2021 Aug 30 9
- ACIP meeting: 2021 Feb-Mar 11
- ACIP meeting: 2021 Feb 24-25 20
- ACIP meeting: 2021 Jan 10
- ACIP meeting: 2021 Jun 23 10
- ACIP meeting: 2021 Jun 24 12
- ACIP meeting: 2021 Jun 25 8
- ACIP meeting: 2021 May 5 6
- ACIP meeting: 2021 May 12 9
- ACIP meeting: 2021 Nov 2 8
- ACIP meeting: 2021 Nov 3 10
- ACIP meeting: 2021 Nov 19 8
- ACIP meeting: 2021 Oct 20 7
- ACIP meeting: 2021 Oct 21 12
- ACIP meeting: 2021 Sep 22-23 15
- ACIP meeting: 2021 Sep 29 14
- ACIP meeting: 2022 Feb 4 12
- ACIP meeting: 2022 Feb 23-24 17
- ACIP meeting: 2022 Jan 12 14
- ACIP meeting: 2022 Jul 19 6
- ACIP meeting: 2022 Jun 17 5
- ACIP meeting: 2022 Jun 18 5
- ACIP meeting: 2022 Jun 22-23 33
- ACIP meeting: 2022 May 19 6
- Centers for Disease Control and Prevention (U.S.) 10
- Child 5
- Coronavirus Infections/prevention & control 15
- COVID-19 Vaccines 13
- COVID-19 Vaccines/adverse effects 4
- GRADE Approach 6
- Influenza, Human 3
- Influenza Vaccines 4
- Janssen COVID-19 vaccine 8
- Janssen COVID-19 Vaccine 9
- Johnson & Johnson’s Janssen COVID-19 vaccine 5
- Moderna COVID-19 Vaccine 7
- Moderna COVID-19 vaccine 18
- Novavax vaccine 3
- Pandemics 11
- Patient Safety 4
- Pfizer-BioNTech COVID-19 Vaccine 14
- Pfizer-BioNTech COVID-19 vaccine 23
- Pneumococcal Infections 4
- Pneumococcal Vaccines 5
- Safety-Based Drug Withdrawals 3
- Thrombocytopenia 4
- Thrombosis 4
- United States. Advisory Committee on Immunization Practices. 7
- United States. Food and Drug Administration. 6
- Vaccination 13
- Vaccine Adverse Event Reporting System 4
- Vaccine Safety Datalink 4
- Viral Vaccines 12
Place as Subject
- Africa 1
- Alabama 1
- Americas 1
- Arizona 1
- Asia 5
- Australia 2
- Colorado 1
- District of Columbia 1
- Indiana 1
- Los Angeles, CA 1
- Louisiana 1
- Maryland 1
- Minnesota 1
- New Jersey 1
- New Mexico 1
- New York City, NY 1
- New Zealand 1
- North Carolina 1
- Puerto Rico 3
- Rhode Island 1
- Seattle, WA 1
- Sierra Leone 1
- South America 1
- United States 247
- Utah 1
- Washington 1
Select all docs (Max 200)
1 -
20 of 1655 Results
Refine Results
Refine Results:
- 2022 (128)
- 2021 (238)
- 2020 (129)
- 2019 (104)
- 2018 (133)
- 2017 (116)
- 2016 (98)
- 2015 (77)
- 2014 (117)
- 2013 (102)
- 2012 (110)
- 2011 (14)
- 2010 (20)
- 2009 (14)
- 2008 (14)
- 2007 (10)
- 2006 (13)
- 2005 (9)
- 2004 (8)
- 2003 (16)
- 2002 (12)
- 2001 (6)
- 2000 (13)
- 1999 (10)
- 1998 (5)
- 1997 (10)
- 1996 (11)
- 1995 (4)
- 1994 (7)
- 1993 (5)
- 1992 (5)
- 1991 (9)
- 1990 (6)
- 1989 (5)
- 1988 (4)
- 1987 (4)
- 1986 (4)
- 1985 (3)
- 1984 (4)
- 1983 (3)
- 1982 (3)
- 1981 (3)
- 1980 (2)
- 1979 (3)
- 1978 (3)
- 1977 (3)
- 1976 (7)
- 1975 (3)
- 1974 (3)
- 1973 (2)
- 1972 (3)
- 1971 (3)
- 1970 (2)
- 1969 (4)
- 1968 (3)
- 1967 (3)
- 1966 (2)
- 1965 (2)
- 1954 (1)
- administration & dosage (32)
- Adolescent (103)
- Adult (99)
- Adverse Drug Reaction Reporting Systems (29)
- adverse effects (20)
- Advisory Committees (61)
- Aged (46)
- Aged, 80 and over (12)
- Age Factors (16)
- Anthrax Vaccines (17)
- Antiviral Agents (20)
- Articles (17)
- Chickenpox Vaccine (12)
- Child (126)
- Child, Preschool (98)
- Cholera Vaccines (12)
- contraindications (13)
- Coronavirus Infections (16)
- Coronavirus Infections/prevention &control (44)
- Coronavirus Infections/prevention & control (195)
- COVID-19 (60)
- COVID-19 Vaccines (210)
- COVID-19 Vaccines/adverse effects (21)
- COVID-19/prevention & control (89)
- Decision Making (18)
- Dengue (13)
- Dengue Vaccines (18)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (22)
- Disease Outbreaks (29)
- Drug-Related Side Effects and Adverse Reactions (13)
- Ebola Vaccines (17)
- Female (35)
- Full Report (22)
- GRADE Approach (35)
- Haemophilus Vaccines (12)
- Health Personnel (21)
- Hepatitis A Vaccines (29)
- Hepatitis B (12)
- Hepatitis B Vaccines (43)
- Herpes Zoster Vaccine (37)
- Humans (146)
- Immunization (334)
- Immunization, Secondary (68)
- Immunization/standards (46)
- Immunization Programs (307)
- Immunization Schedule (177)
- Immunocompromised Host (16)
- Infant (93)
- Infant, Newborn (29)
- Influenza, Human (47)
- Influenza, Human/prevention & control (15)
- Influenza A virus (13)
- Influenza A Virus, H1N1 Subtype (13)
- Influenza B virus (19)
- Influenza Vaccines (159)
- Influenza Vaccines/adverse effects (12)
- Influenza Vaccines (12)
- Japanese Encephalitis Vaccines (32)
- Licensure (12)
- Male (27)
- Mass Vaccination (12)
- Measles-Mumps-Rubella Vaccine (29)
- Meningococcal Infections (17)
- Meningococcal Vaccines (86)
- Middle Aged (47)
- Myocarditis (13)
- Pandemics (150)
- Papillomavirus Vaccines (53)
- Papillomavirus Vaccines (34)
- Patient Safety (44)
- Pertussis Vaccine (34)
- Pneumococcal Infections (14)
- Pneumococcal Vaccines (72)
- Practice Guidelines as Topic (34)
- Pregnancy (31)
- prevention & control (34)
- Program Evaluation (15)
- Public Health Surveillance (12)
- Rabies Vaccines (12)
- Risk Assessment (12)
- Risk Factors (16)
- Safety (25)
- Seasons (14)
- Smallpox Vaccine (15)
- standards (43)
- Travel (19)
- Vaccination (576)
- Vaccination/adverse effects (13)
- Vaccination/standards (19)
- Vaccines (317)
- Vaccines, Attenuated (22)
- Vaccines, Combined (19)
- Vaccines, Conjugate (19)
- Vaccines, Inactivated (21)
- Vaccines/administration & dosage (45)
- Vaccines/supply & distribution (18)
- Viral Hepatitis Vaccines (12)
- Viral Vaccines (154)
- Yellow Fever Vaccine (12)
- Young Adult (28)
- ACIP Meeting 2021 April 23 (2)
- ACIP Meeting 2021 January 27 (4)
- ACIP meeting: 1975 Oct (2)
- ACIP meeting: 2002 Feb (2)
- ACIP meeting: 2002 Jun (2)
- ACIP meeting: 2002 Oct (2)
- ACIP meeting: 2003 Feb (2)
- ACIP meeting: 2003 Jun (2)
- ACIP meeting: 2003 Oct (3)
- ACIP meeting: 2012 Jun (5)
- ACIP meeting: 2012 Oct (37)
- ACIP meeting: 2013 Feb (28)
- ACIP meeting: 2013 Jun (28)
- ACIP meeting: 2013 Oct (33)
- ACIP meeting: 2014 Aug (4)
- ACIP meeting: 2014 Feb (33)
- ACIP meeting: 2014 Jun (37)
- ACIP meeting: 2014 Oct (29)
- ACIP meeting: 2015 Feb (13)
- ACIP meeting: 2015 Jun (31)
- ACIP meeting: 2015 Oct (22)
- ACIP meeting: 2016 Feb (22)
- ACIP meeting: 2016 Jun (35)
- ACIP meeting: 2016 Oct (39)
- ACIP meeting: 2017 Feb (35)
- ACIP meeting: 2017 Jun (29)
- ACIP meeting: 2017 Oct (50)
- ACIP meeting: 2018 Feb (35)
- ACIP meeting: 2018 Jun (30)
- ACIP meeting: 2018 Oct (36)
- ACIP meeting: 2019 Feb (38)
- ACIP meeting: 2019 Jun (33)
- ACIP meeting: 2019 Oct (20)
- ACIP meeting: 2020 Aug (8)
- ACIP meeting: 2020 Dec 01 (5)
- ACIP meeting: 2020 Dec 11 (5)
- ACIP meeting: 2020 Dec 11-12 (3)
- ACIP meeting: 2020 Dec 19-20 (10)
- ACIP meeting: 2020 Feb (26)
- ACIP meeting: 2020 Jul (11)
- ACIP meeting: 2020 Jun (14)
- ACIP meeting: 2020 Nov (9)
- ACIP meeting: 2020 Oct (13)
- ACIP meeting: 2020 Sep (10)
- ACIP meeting: 2021 Apr. 14 (5)
- ACIP meeting: 2021 Apr. 23 (6)
- ACIP meeting: 2021 Aug 13 (6)
- ACIP meeting: 2021 Aug 30 (9)
- ACIP meeting: 2021 Feb-Mar (11)
- ACIP meeting: 2021 Feb 24-25 (20)
- ACIP meeting: 2021 Jan (10)
- ACIP meeting: 2021 Jun 23 (10)
- ACIP meeting: 2021 Jun 24 (12)
- ACIP meeting: 2021 Jun 25 (8)
- ACIP meeting: 2021 May 5 (6)
- ACIP meeting: 2021 May 12 (9)
- ACIP meeting: 2021 Nov 2 (8)
- ACIP meeting: 2021 Nov 3 (10)
- ACIP meeting: 2021 Nov 19 (8)
- ACIP meeting: 2021 Oct 20 (7)
- ACIP meeting: 2021 Oct 21 (12)
- ACIP meeting: 2021 Sep 22-23 (15)
- ACIP meeting: 2021 Sep 29 (14)
- ACIP meeting: 2022 Feb 4 (12)
- ACIP meeting: 2022 Feb 23-24 (17)
- ACIP meeting: 2022 Jan 12 (14)
- ACIP meeting: 2022 Jul 19 (6)
- ACIP meeting: 2022 Jun 17 (5)
- ACIP meeting: 2022 Jun 18 (5)
- ACIP meeting: 2022 Jun 22-23 (33)
- ACIP meeting: 2022 May 19 (6)
- Centers for Disease Control and Prevention (U.S.) (10)
- Child (5)
- Coronavirus Infections/prevention & control (15)
- COVID-19 Vaccines (13)
- COVID-19 Vaccines/adverse effects (4)
- GRADE Approach (6)
- Influenza, Human (3)
- Influenza Vaccines (4)
- Janssen COVID-19 vaccine (8)
- Janssen COVID-19 Vaccine (9)
- Johnson & Johnson’s Janssen COVID-19 vaccine (5)
- Moderna COVID-19 Vaccine (7)
- Moderna COVID-19 vaccine (18)
- Novavax vaccine (3)
- Pandemics (11)
- Patient Safety (4)
- Pfizer-BioNTech COVID-19 Vaccine (14)
- Pfizer-BioNTech COVID-19 vaccine (23)
- Pneumococcal Infections (4)
- Pneumococcal Vaccines (5)
- Safety-Based Drug Withdrawals (3)
- Thrombocytopenia (4)
- Thrombosis (4)
- United States. Advisory Committee on Immunization Practices. (7)
- United States. Food and Drug Administration. (6)
- Vaccination (13)
- Vaccine Adverse Event Reporting System (4)
- Vaccine Safety Datalink (4)
- Viral Vaccines (12)
- Africa (1)
- Alabama (1)
- Americas (1)
- Arizona (1)
- Asia (5)
- Australia (2)
- Colorado (1)
- District of Columbia (1)
- Indiana (1)
- Los Angeles, CA (1)
- Louisiana (1)
- Maryland (1)
- Minnesota (1)
- New Jersey (1)
- New Mexico (1)
- New York City, NY (1)
- New Zealand (1)
- North Carolina (1)
- Puerto Rico (3)
- Rhode Island (1)
- Seattle, WA (1)
- Sierra Leone (1)
- South America (1)
- United States (247)
- Utah (1)
- Washington (1)
- File Format:
- RIS
- File Format:
- RIS
Advisory Committee on Immunization Practices (ACIP) summary report : February 24-25, 2010, Atlanta, Georgia
Cite
[PDF - 2.44 MB]
Corporate Authors:
United States. Advisory Committee on Immunization Practices.
2010 | ACIP meeting Minutes
Description:
min-feb10.pdf
File Type:
[PDF - 2.44 MB]
File Type:
[PDF - 2.44 MB]
[PDF - 501.54 KB]
Personal Author:
Bell, Beth P.
December 19, 2020 | ACIP meeting COVID-19 Vaccines
Description:
01-COVID-Bell-508.pdf
File Type:
[PDF - 501.54 KB]
File Type:
[PDF - 501.54 KB]
[PDF - 704.27 KB]
Personal Author:
Miller, Jacqueline M.
December 19, 2020 | ACIP meeting COVID-19 Vaccines
Description:
02-COVID-Miller-508.pdf
File Type:
[PDF - 704.27 KB]
File Type:
[PDF - 704.27 KB]
Grading of recommendations, assessment, development, and evaluation (GRADE) : Moderna COVID-19 vaccine
Cite
[PDF - 570.75 KB]
Personal Author:
Gargano, Julia W.
December 19, 2020 | ACIP meeting COVID-19 Vaccines
Description:
03-COVID-Gargano-508.pdf
File Type:
[PDF - 570.75 KB]
File Type:
[PDF - 570.75 KB]
[PDF - 4.20 MB]
Personal Author:
Oliver, Sara E.
December 19, 2020 | ACIP meeting COVID-19 Vaccines
Description:
slides-12-19/04-COVID-Oliver-508.pdf
File Type:
[PDF - 4.20 MB]
File Type:
[PDF - 4.20 MB]
[PDF - 599.17 KB]
Personal Author:
Clark, Thomas A.
December 19, 2020 | ACIP meeting COVID-19 Vaccines
Description:
05-COVID-CLARK-508.pdf
File Type:
[PDF - 599.17 KB]
File Type:
[PDF - 599.17 KB]
[PDF - 1.43 MB]
Personal Author:
Mbaeyi, Sarah A.
December 19, 2020 | ACIP meeting COVID-19 Vaccines
Description:
06-COVID-Mbaeyi-508.pdf
File Type:
[PDF - 1.43 MB]
File Type:
[PDF - 1.43 MB]
[PDF - 449.76 KB]
Personal Author:
Bell, Beth P.
December 20, 2020 | ACIP meeting COVID-19 Vaccines
Description:
01-COVID-Bell-508.pdf
File Type:
[PDF - 449.76 KB]
File Type:
[PDF - 449.76 KB]
[PDF - 968.80 KB]
Personal Author:
Dooling, Kathleen
December 20, 2020 | ACIP meeting COVID-19 Vaccines
Description:
02-COVID-Dooling-508.pdf
File Type:
[PDF - 968.80 KB]
File Type:
[PDF - 968.80 KB]
[PDF - 1.05 MB]
Personal Author:
Oliver, Sara E.
December 20, 2020 | ACIP meeting COVID-19 Vaccines
Description:
03-COVID-Oliver-508.pdf
File Type:
[PDF - 1.05 MB]
File Type:
[PDF - 1.05 MB]
[PDF - 3.27 MB]
Personal Author:
Gruber, William
December 11, 2020 | ACIP meeting COVID-19 Vaccines
Description:
COVID-02-Gruber-508.pdf
File Type:
[PDF - 3.27 MB]
File Type:
[PDF - 3.27 MB]